Company:  AXOGEN, INC. (AXGN)
Form Type:  8-K
Filing Date:  7/11/2013 
CIK:  0000805928 
Address:  13631 PROGRESS BLVD.
SUITE 400
 
City, State, Zip:  ALACHUA, Florida 32615 
Telephone:  (386) 462-6817 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$51.35  
Change: 
-0.40 (-0.77%)  
Trade Time: 
Jun 22  
Market Cap: 
$1.96B
Trade AXGN now with 

© 2018  
Description of Business
We are a global leader in developing and marketing surgical solutions for peripheral nerves. We provide products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Our portfolio of products includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix ("ECM") coaptation aid for tensionless repair of severed peripheral nerves, AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments and Avive® Soft Tissue Membrane, a minimally processed human umbilical cord membrane that may be used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed.
Register and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02 Results of Operations and Financial Condition
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits
    SIGNATURE
    EXHIBIT INDEX
  EXHIBIT 99.1
    BALANCE SHEET
    INCOME STATEMENT
    CASH FLOW